Skip to main navigation Skip to search Skip to main content

Phase 2 study of intermittent pulse dacomitinib in patients with advanced non-small cell lung cancers

  • Helena A. Yu
  • , Myung Ju Ahn
  • , Byoung Chul Cho
  • , David E. Gerber
  • , Ronald B. Natale
  • , Mark A. Socinski
  • , Nagdeep Giri
  • , Susan Quinn
  • , Eric Sbar
  • , Hui Zhang
  • , Giuseppe Giaccone
  • Memorial Sloan-Kettering Cancer Center
  • Yonsei University
  • University of Texas Southwestern Medical Center
  • Cedars-Sinai Medical Center
  • University of Pittsburgh
  • AdventHealth Orlando
  • Pfizer
  • Georgetown University

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Phase 2 study of intermittent pulse dacomitinib in patients with advanced non-small cell lung cancers'. Together they form a unique fingerprint.
Sort by

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science